Posted on by sciencefather
71 / 100
Powered by Rank Math SEO

Dr. Hui-Hsin Ko | Oral oncology | Best Researcher Award

Dr . Hui-Hsin Ko National Taiwan University Hsin-Chu Hospital Taiwan

Dr. Hui-Hsin Ko is an Assistant Professor and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hsin-Chu Hospital. With a DDS, MS, and PhD from National Taiwan University, she has extensive expertise in oral and maxillofacial surgery, specializing in cancer surgeries, temporomandibular joint (TMJ) surgeries, and zygomatic implantation. Dr. Ko’s research focuses on oral squamous cell carcinoma, with multiple publications in SCI-indexed journals. She has contributed significantly to the field of cancer research by exploring biomarkers such as AKR1B10, advancing both the understanding and treatment of oral cancers. Dr. Ko’s achievements in research and clinical practice have set a high standard for innovation in her field.

 

profile

scopus

Academic and Professional Background 🎓

Dr. Hui-Hsin Ko is a Clinical Assistant Professor at National Taiwan University and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hospital, Hsin-Chu Branch. She holds a DDS, MS, and PhD from National Taiwan University, with specialization in oral and maxillofacial surgery. Her expertise includes temporomandibular joint surgery, cancer surgery, and zygomatic implantation. A diplomate of the Taiwan Board of Oral and Maxillofacial Surgery, Dr. Ko has authored several publications, significantly contributing to oral squamous cell carcinoma research.

Research and Innovations 💡

Completed/Ongoing Research Projects: AKR1B10-related, TMJ arthroscopy-related, oral cancer-related.Citation Index: Information available on indexed platformsConsultancy/Industry Projects: To be updated Books Published (ISBN): No books published yet.Patents Published/Under Process: To be updated.Journals Published (SCI, Scopus, etc.): Multiple articles published in SCI-indexed journals

Editorial Appointments ✍️

To be updated.

Collaborations 🤝

Dr. Ko has actively collaborated with medical professionals and researchers in Taiwan to advance studies in oral squamous cell carcinoma and oral health-related surgeries.

Professional Memberships 📜

Diplomate of the Taiwan Board of Oral and Maxillofacial Surgery.Member of various oral and maxillofacial surgical associations

Areas of Research 🔬

Oral squamous cell carcinoma.Temporomandibular joint surgery.Zygomatic implantation.Cancer surgery

Contributions 🌟

Dr. Hui-Hsin Ko has significantly contributed to cancer research, especially in identifying biomarkers for oral squamous cell carcinoma progression. Her work on AKR1B10 levels has opened new pathways in understanding the poor prognosis of the disease. She has also explored advanced surgical techniques, including TMJ surgery and zygomatic implantation, contributing to improved patient outcomes.

 

📚 Publications

  • Title: The dental implant survival rate in 18 patients with post-operation revolutionary jaw reconstruction using free fibular flap, dental implants, and overdentures
    Author(s): Ko, H.-H., Chou, C.-H., Cheng, S.-J.
    Year: 2024

 

  • Title: Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma
    Author(s): Shie, W.-Y., Cheng, S.-J., Chen, K.-C., Hou, H.-H., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines
    Author(s): Ko, H.-H., Chou, H.-Y.E., Hou, H.-H., Yen-Ping Kuo, M., Cheng, S.-J.
    Year: 2024

 

  • Title: Prosthetic-Driven Autotransplantation with the Assistance of Medical Image-Processing Software and a Real-Time Navigation System: A Case Report
    Author(s): Chang, H.-M., Ko, H.-H., Chi, C.-W., Lin, I.-P., Chen, S.-H.
    Year: 2024

 

  • Title: Evaluation of the prognostic and therapeutic potential of inhibin beta B for oral squamous cell carcinoma
    Author(s): Chung, Y.-Y., Cheng, S.-J., Ko, H.-H., Shie, W.-Y., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP β-glucan in oral squamous cell carcinoma
    Author(s): Ko, H.-H., Peng, H.-H., Cheng, A.N., Lee, A.Y.-L., Cheng, S.-J.
    Year: 2023

 

  • Title: Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3
    Author(s): Lu, Y.-J., Deng, Y.-T., Ko, H.-H., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2023

 

  • Title: ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions
    Author(s): Juan, Y.-C., Su, Y.-F., Bai, C.-H., Fwu, C.-W., Cheng, S.-J.
    Year: 2023

 

  • Title: β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients
    Author(s): Lo, Y.-W., Lee, A.Y.-L., Liu, Y.-C., Chiang, C.-P., Cheng, S.-J.
    Year: 2022

 

  • Title: Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan
    Author(s): Peng, H.-H., Ko, H.-H., Chi, N.-C., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2020

 

Conclusion

Dr. Hui-Hsin Ko’s extensive background in oral and maxillofacial surgery, coupled with her impressive research contributions to the understanding of oral squamous cell carcinoma, makes her a strong candidate for the Best Researcher Award. Her dedication to advancing cancer research, her innovative surgical techniques, and her collaborative efforts in the medical field demonstrate her leadership and impact. Dr. Ko has not only excelled in her clinical practice but has also significantly contributed to scientific advancements that benefit patients globally.

 

 

Hui-Hsin Ko | Oral oncology | Best Researcher Award

You May Also Like